Cabot (NYSE:CBT) Rating Lowered to “Hold” at Mizuho

Cabot (NYSE:CBT) was downgraded by investment analysts at Mizuho from a “strong-buy” rating to a “hold” rating in a note issued to investors on Wednesday,Zacks.com reports.

CBT has been the subject of a number of other reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cabot in a research report on Monday, December 29th. Zacks Research upgraded shares of Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 27th. JPMorgan Chase & Co. cut their price objective on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research report on Friday, November 28th. UBS Group lifted their target price on shares of Cabot from $74.00 to $81.00 and gave the company a “neutral” rating in a report on Thursday. Finally, Jefferies Financial Group reissued a “buy” rating and set a $85.00 price target on shares of Cabot in a report on Wednesday. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $73.75.

Cabot Trading Down 3.0%

NYSE:CBT opened at $76.39 on Wednesday. The company has a quick ratio of 1.08, a current ratio of 1.67 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $4.04 billion, a PE ratio of 13.38, a P/E/G ratio of 4.12 and a beta of 0.88. The stock’s 50 day moving average price is $69.04 and its 200 day moving average price is $71.69. Cabot has a 52-week low of $58.33 and a 52-week high of $89.15.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.13. The firm had revenue of $849.00 million during the quarter, compared to analysts’ expectations of $889.11 million. Cabot had a net margin of 8.62% and a return on equity of 22.81%. Cabot’s quarterly revenue was down 11.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.76 EPS. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. On average, research analysts anticipate that Cabot will post 7.57 EPS for the current year.

Institutional Investors Weigh In On Cabot

Institutional investors and hedge funds have recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. raised its holdings in Cabot by 56,330.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 107,218 shares of the specialty chemicals company’s stock worth $7,106,000 after purchasing an additional 107,028 shares during the last quarter. Isthmus Partners LLC purchased a new position in Cabot during the 4th quarter valued at about $1,486,000. Leeward Investments LLC MA lifted its holdings in shares of Cabot by 15.6% in the fourth quarter. Leeward Investments LLC MA now owns 230,092 shares of the specialty chemicals company’s stock valued at $15,250,000 after purchasing an additional 30,976 shares in the last quarter. Allworth Financial LP increased its stake in shares of Cabot by 22.4% during the 4th quarter. Allworth Financial LP now owns 1,455 shares of the specialty chemicals company’s stock worth $96,000 after purchasing an additional 266 shares in the last quarter. Finally, West Tower Group LLC acquired a new position in shares of Cabot during the 4th quarter worth approximately $745,000. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.